Home Newsfeeds Barclays Maintains Equal-Weight on Plains All American, Raises Price Target to $13

Barclays Maintains Equal-Weight on Plains All American, Raises Price Target to $13

Barclays analyst Theresa Chen maintains Plains All American (NASDAQ: PAA) with a Equal-Weight and raises the price target from $12 to $13.Barclays analyst Theresa Chen maintains Plains All American (NASDAQ:PAA) with a Equal-Weight and raises the price

byBenzinga Newsdesk

August 16, 2022

1 minute read

Barclays analyst Theresa Chen maintains Plains All American (NASDAQ:PAA) with a Equal-Weight and raises the price target from $12 to $13.Barclays analyst Theresa Chen maintains Plains All American (NASDAQ:PAA) with a Equal-Weight and raises the price target from $12 to $13.

Why Is Infectious Disease Focused 60 Degrees Pharmaceuticals Stock Trading Lower Today?

By Vandana Singh

September 19, 9:04 AM

60 Degrees Pharmaceuticals Inc's (NASDAQ: SXTP) subsidiary, 60P Australia Pty Ltd, has withdrawn its investigational new drug (IND) application for ACLR8-LR, a Phase 2B study of the use of tafenoquine

SXTP

Actinium Announces KOL Webinar To Highlight Recently Announced Iomab-ACT Trial With Leading FDA Approved Commercial CAR T-Cell Therapy Being Led By The University Of Texas Southwestern

By Benzinga Newsdesk

May 7, 8:21 AM

Dr. Farrukh Awan, Professor of Medicine, Division of Hematology Oncology at University of Texas Southwestern and Principal Investigator for the trial to join Actinium management for webinarExpansion of Iomab-ACT program

ATNM

Global
News

North Korea Fires Ballistic Missile

By Michael Horton

October 5, 5:08 PM

-Reuters

SPY

Investor Fear Increases Following Fed’s Rate Hike

By Lisa Levin

March 23, 2:42 AM

The CNN Money Fear and Greed index showed some increase in the fear level among U.S. investors. US stocks tumbled on Wednesday after the Federal Reserve raised rates another 0.25%, marking its ninth straight rate increase. Shares of regional banks moved lower on Wednesday, with the S&P Regional Bank ETF dropping over 5%.

ACN

Barclays Maintains Equal-Weight on Plains All American, Raises Price Target to $13

Related Posts

Why Is Infectious Disease Focused 60 Degrees Pharmaceuticals Stock Trading Lower Today?

Actinium Announces KOL Webinar To Highlight Recently Announced Iomab-ACT Trial With Leading FDA Approved Commercial CAR T-Cell Therapy Being Led By The University Of Texas Southwestern

North Korea Fires Ballistic Missile

Investor Fear Increases Following Fed’s Rate Hike